... spring, like budding trees, are worth celebrating...of fertile, winged termites swarming furiously to ... In New Orleans, as the swirling, airborne masses ...ith the Agricultural Research Service (ARS) are bu...ock down large numbers of Formosan subterranean te...
...e about "superbugs" that defy current treatments h...urrounding the issue of antibiotic resistance. A n...ow Bacterial Resistance is Undermining the Antibio...subject in a reader-friendly, comprehensible style...yday citizens. , "Most people have a love-hate rel...
...t the University of Iowa Roy J. and Lucille A. Car...ward a potential treatment for Huntington,s diseas...(RNAi), the scientists reduced levels of the disea...proved the movement and neurological abnormalities...stating, inherited, neurodegenerative disease that...
Other Biology News:Fungus Effective Against Winged Termites 2New book explains antibiotic resistance for a broad audience 2U. Iowa researchers improve Huntington's disease symptoms in mice 2U. Iowa researchers improve Huntington's disease symptoms in mice 3(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)TUSTIN, Calif., Dec. 3 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that it will release its financial results for the second quarter of fiscal year 2010 on December 10, 2009 at 7
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Neurostimulation - A Global Market Perspective ,, http://www.reportlinker.com/p01642
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6...treatments to cancer patients worldwide might have...ison medical-device firm with more than 200 employ...go public within a year, its founder said. , ,The ...on professor who was spurred into going commercial...logy research projects. , ,"I thought they were to...
...e Digital Healthcare Conference 2005 in Madison ...hapman knows a thing or two about how to make thin...tion technology (HIT). , ,After serving as CIO at... Drug Administration and Department of Health an...gh-flying IT projects notably, an effort at FDA t...
...t your card in an ATM in San Francisco, the system...ur financial records. But if you find yourself in ...d to pay for an extensive series of tests because ... your hometown doctor,s office. , ,Information tec...es, including instant global transfer and tight se...
Other Biology Technology:TomoTherapy considers IPO with medical-device business on the rise 2TomoTherapy considers IPO with medical-device business on the rise 3IT guru Melissa Chapman: how to make health IT work for the bottom line 2IT guru Melissa Chapman: how to make health IT work for the bottom line 3IT guru Melissa Chapman: how to make health IT work for the bottom line 4IT guru Melissa Chapman: how to make health IT work for the bottom line 5Physician mindset slows adoption of electronic health records 2Physician mindset slows adoption of electronic health records 3Physician mindset slows adoption of electronic health records 4F40 Piston Seals, 2 from Bio-Rad
StemSep Rhesus T Cell Purging, 2 mL Kit from StemCell Technologies, Inc.
CheckMate Mammalian Two-Hybrid System from Promega
StemSep Rhesus CD4+ T Cells, 2 mL Kit from StemCell Technologies, Inc.
Biology Products: